Corcept Therapeutics reported $6.81B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Alaunos Therapeutics USD 6M 1000K Jun/2026
ANI Pharmaceuticals USD 1.46B 206M Nov/2026
Ardelyx USD 718M 542M Nov/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Corcept Therapeutics USD 7.63B 4.83B Nov/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 375.59B 17.09B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Novartis USD 328.21B 54.92B Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
TG Therapeutics USD 10B 1.46B Nov/2026